FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, specifically to a solid solution composition capable of normalising lipid level. Pharmaceutical solid solution composition, capable of normalising lipid level. Use of the pharmaceutical solid solution composition in the manufacture of a medicinal product and for the treatment of a cardiovascular disease (versions). Method of treating an individual suffering from a cardiovascular disease, where the method includes steps of: administering to the individual, if necessary, the pharmaceutical solid solution composition, where the administration results in reduction of the intensity of the symptom associated with a cardiovascular disease, resulting in the treatment of the individual. Said composition is a monophasic solid solution composition.
EFFECT: solid solution compositions and their use in cardiovascular disease are disclosed.
18 cl, 13 dwg, 7 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2675241C2 |
SOLID SOLUTION COMPOSITIONS AND THEIR USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2779839C2 |
SOLID SOLUTION COMPOSITIONS AND USE IN SEVERE PAIN | 2014 |
|
RU2667977C2 |
PRO-MEDICATION COMPOSITION FOR STRUGGLE AGAINST HEPAPATITIS C VIRUS | 2006 |
|
RU2435592C2 |
COMPOSITIONS AND METHODS FOR TREATING SEVERE PAIN | 2014 |
|
RU2677346C2 |
COMPOSITIONS AND METHODS OF TREATING CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES | 2014 |
|
RU2680801C2 |
PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS | 2012 |
|
RU2640912C2 |
FORMULATIONS FOR ORAL ADMINISTRATION OF DRUG PREPARATIONS AND RELATED METHODS | 2008 |
|
RU2485975C2 |
PHARMACEUTICAL COMPOSITION FOR HIV INFECTION TREATMENT | 2016 |
|
RU2619840C1 |
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
Authors
Dates
2018-12-14—Published
2014-01-14—Filed